About Godavari Biorefineries Limited
Data last updated: 22 December 2025
Godavari Biorefineries Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in organic chemicals and compounds, a part of the broader chemicals and materials sector. Incorporated on 12 January 1956, the company has been in operation for over 70 years.
Registered with ROC Mumbai under CIN L67120MH1956PLC009707. Listed.
Capital: an authorised share capital of ₹100 Cr and a paid-up capital of ₹51.18 Cr. Formerly known as Godavari Investment and Finance Corporation Ltmited and Godavari Investment and Finance Corporation Private Ltmited. It is led by directors including Bhalachandra Raghavendra Bakshi and Samir Shantilal Somaiya.
Last AGM: 16 September 2024. Financial statements filed for year ended 31 March 2024. Office: Somaiya Bhavan 45/47 M. G. Road Fort, Mumbai, Maharashtra, India – 400001.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,886.91 Cr, a growth of 11% compared to the previous year.
The company has a workforce of approximately 1,482 employees as per the latest available data.
The company is associated with 4 brands - Sathgen Therapeutics, Godavari Bio Fertilizer Industries, Somaiya Group, Godavari Biorefineries. As per MCA filings, the company has open charges of ₹1,508.63 Cr and satisfied charges of ₹1,824.27 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website somaiya.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media
-
Registered AddressSomaiya Bhavan 45/47 M. G. Road Fort, Mumbai, Maharashtra, India – 400001
-
IndustryChemicals and Materials, Organic Chemicals & Compounds, Specialty Chemicals
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Godavari Biorefineries Limited
Godavari Biorefineries Limited has undergone 2 name changes throughout its history. The company was previously known as Godavari Investment And Finance Corporation Ltmited, and Godavari Investment And Finance Corporation Private Ltmited. The current legal name is Godavari Biorefineries Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Godavari Biorefineries Limited | Current |
| Godavari Investment And Finance Corporation Ltmited | Previous |
| Godavari Investment And Finance Corporation Private Ltmited | Previous |
CIN History of Godavari Biorefineries Limited
Godavari Biorefineries Limited has one previous CIN (Corporate Identification Number): U67120MH1956PLC009707. The current CIN is L67120MH1956PLC009707, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L67120MH1956PLC009707 | Current |
| U67120MH1956PLC009707 | Previous |
Associated Brands with Godavari Biorefineries Limited
Godavari Biorefineries Limited operates multiple associated brands including Sathgen Therapeutics, Godavari Bio Fertilizer Industries, and Somaiya Group. These brands represent Godavari Biorefineries Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Clinical-stage biotech firm developing cancer treatments and antiviral drugs through trials. | sathgentherapeutics.com | |
| Produces high-quality bio-fertilizers and animal feed supplements. | godavaribio.com | |
| Biofuels and specialty chemicals are manufactured in India. | somaiya.com | |
| Manufacturer of bio-based chemicals, sugar, alcohol, biofuels, power, and related products | godavaribiorefineries.com |
Competitors & Alternatives of Godavari Biorefineries Limited
Brands and companies operating in the same space as Godavari Biorefineries Limited include Moderna, Jazz Pharmaceuticals, Advanced Accelerator Applications and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Moderna
|
mRNA-based therapeutics for diseases including cancer and infections are developed. | Cambridge, United States, United States | 2010 |
Jazz Pharmaceuticals
|
Novel biopharmaceutical medicines are developed for unmet medical needs. | Dublin, Ireland, Ireland | 2003 |
Advanced Accelerator Applications
|
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. | Saint Genis Pouilly, France, France | 2002 |
C4 Therapeutics
|
Small-molecule drugs for cancer treatment are developed via Degronimid platform. | Cambridge, United States, United States | 2016 |
BeiGene
|
Targeted and immune-oncology drugs for cancer treatment are developed. | Cambridge, United States, United States | 2010 |
Syndax
|
Targeted therapies for cancer treatment are developed. | Waltham, United States, United States | 2005 |
Revolution Medicines
|
Cancer therapies are developed using selective pathway inhibitors. | Redwood City, United States, United States | 2014 |
Ginkgo Bioworks
|
Gene editing-based cultured ingredients are provided for agriculture. | Boston, United States, United States | 2008 |
Blueprint Medicines
|
Selective kinase inhibitors are developed for genomically defined cancers. | Cambridge, United States, United States | 2008 |
Incyte
|
Small molecules are developed for cancer and skin disease treatments. | Wilmington, United States, United States | 1991 |
Business Activity of Godavari Biorefineries Limited
Godavari Biorefineries Limited is engaged in the principal business activity of manufacturing, with detailed activities including food, beverages and tobacco products, chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C1 | Food, beverages and tobacco products | ********* |
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Godavari Biorefineries Limited
Godavari Biorefineries Limited is audited by VERMA MEHTA & ASSOCIATES (ICAI peer reviewed, certificate valid till 2028-08-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| VERMA MEHTA & ASSOCIATES (ICAI peer reviewed, certificate valid till 2028-08-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Godavari Biorefineries Limited
Godavari Biorefineries Limited is currently managed by 14 directors, with 33 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Bhalachandra Raghavendra Bakshi
Also directs:
Solar Magic Private Limited
|
Whole-Time Director | 01 Jun 2018 | 8 Years 1 Months | Current |
|
Samir Shantilal Somaiya
Also directs:
Solar Magic Private Limited, Sakarwadi Trading Company Private Limited, Lakshmiwadi Mines And Minerals Private Limited and 5 more
|
Managing Director | 22 Jun 2007 | 19 Years 0 Months | Current |
| Sean Edward Reagan | Director | 30 Sep 2025 | 0 Years 9 Months | Current |
| Nitin Mehta | Director | 01 Jul 2021 | 5 Years 0 Months | Current |
| Sangeeta Srivastava Arunkumar | Whole-Time Director | 01 Aug 2020 | 5 Years 11 Months | Current |
|
Hemant Luthra
Also directs:
Dimensions Corporate Finance Services Private Limited
|
Director | 27 Sep 2019 | 6 Years 9 Months | Current |
Financials of Godavari Biorefineries Limited FY 2026 filings available
Godavari Biorefineries Limited reported revenue of ₹1,987.94 Cr (up 6.29% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Revenue from Operations | ₹1,987.94 Cr | ₹1,870.25 Cr |
| Other Income | ₹12.21 Cr | ₹16.66 Cr |
| Total Income | ₹2,000.15 Cr | ₹1,886.91 Cr |
| Cost of Materials Consumed | ₹1,489.06 Cr | ₹1,242.75 Cr |
| Purchases of Stock-in-Trade | ₹28.91 Cr | ₹17.8 Cr |
| Changes in Inventories | -₹91.36 Cr | ₹124.61 Cr |
| Employee Benefit Expense | ₹135.22 Cr | ₹125.35 Cr |
| Finance Costs | ₹49.13 Cr | ₹71.79 Cr |
| Depreciation & Amortisation | ₹54.49 Cr | ₹50.06 Cr |
| Other Expenses | ₹298.99 Cr | ₹256.1 Cr |
| Total Expenses | ₹1,964.45 Cr | ₹1,888.45 Cr |
| Profit Before Exceptional Items & Tax | ₹35.71 Cr | -₹1.54 Cr |
| Exceptional Items | -₹31.14 Cr | ₹0 |
| Profit Before Tax | ₹4.57 Cr | -₹1.54 Cr |
| Total Tax Expense | ₹1.04 Cr | ₹21.88 Cr |
| Net Profit | ₹3.53 Cr | -₹23.41 Cr |
| attributable to Owners | ₹0 | ₹0 |
| attributable to NCI | ₹0 | ₹0 |
| Other Comprehensive Income | ₹92.42 Lakh | -₹32.4 Lakh |
| Total Comprehensive Income | ₹4.45 Cr | -₹23.74 Cr |
| EBITDA (computed) | ₹139.33 Cr | ₹120.31 Cr |
| Basic EPS | ₹0.69 | ₹-5.11 |
| Diluted EPS | ₹0.69 | ₹-5.11 |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Total Assets | ₹2,052.25 Cr | ₹1,955.09 Cr |
| Non-current Assets | ₹1,060.73 Cr | ₹931.83 Cr |
| Current Assets | ₹991.52 Cr | ₹1,023.26 Cr |
| Property, Plant & Equipment | ₹864.09 Cr | ₹861.55 Cr |
| Inventories | ₹775.8 Cr | ₹739.71 Cr |
| Trade Receivables | ₹113.6 Cr | ₹138.22 Cr |
| Cash & Equivalents | ₹15.25 Cr | ₹12.25 Cr |
| Equity (Net Worth) | ₹788.29 Cr | ₹781.96 Cr |
| Equity Share Capital | ₹51.18 Cr | ₹51.18 Cr |
| Borrowings (Non-current) | ₹333.32 Cr | ₹239.74 Cr |
| Borrowings (Current) | ₹196.76 Cr | ₹249.67 Cr |
| Total Debt (computed) | ₹530.08 Cr | ₹489.41 Cr |
| Current Liabilities | ₹874.41 Cr | ₹884.26 Cr |
| Total Liabilities | ₹1,263.96 Cr | ₹1,173.12 Cr |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Operating Cash Flow | ₹171.33 Cr | ₹6.15 Cr |
| Investing Cash Flow | -₹162.58 Cr | -₹68.76 Cr |
| Financing Cash Flow | -₹5.74 Cr | ₹63.74 Cr |
| Capital Expenditure | ₹168.93 Cr | ₹71.28 Cr |
| Free Cash Flow (computed) | ₹2.4 Cr | -₹65.13 Cr |
| Dividends Paid | ₹0 | ₹0 |
| Net Change in Cash | ₹3 Cr | ₹1.14 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹564.1 Cr | ₹459.85 Cr | ₹430.75 Cr | ₹533.24 Cr | ₹579.5 Cr | ₹447.27 Cr | ₹320.95 Cr |
| Other Income | ₹5.9 Cr | ₹2.06 Cr | ₹3.52 Cr | ₹73.79 Lakh | ₹9.25 Cr | ₹3.56 Cr | ₹1.1 Cr |
| Total Income | ₹570 Cr | ₹461.91 Cr | ₹434.27 Cr | ₹533.97 Cr | ₹588.76 Cr | ₹450.83 Cr | ₹322.06 Cr |
| Cost of Materials Consumed | ₹681.79 Cr | ₹455.56 Cr | ₹146.21 Cr | ₹205.51 Cr | ₹575.31 Cr | ₹446.61 Cr | ₹92.49 Cr |
| Purchases of Stock-in-Trade | ₹6.11 Cr | ₹4.95 Cr | ₹9.49 Cr | ₹8.35 Cr | ₹4.73 Cr | ₹3 Cr | ₹4.88 Cr |
| Changes in Inventories | -₹341.61 Cr | -₹154.64 Cr | ₹187.19 Cr | ₹217.69 Cr | -₹222.48 Cr | -₹142.39 Cr | ₹171.57 Cr |
| Employee Benefit Expense | ₹36.72 Cr | ₹34.79 Cr | ₹31.54 Cr | ₹32.17 Cr | ₹34.91 Cr | ₹30.38 Cr | ₹29.66 Cr |
| Finance Costs | ₹11.3 Cr | ₹10.21 Cr | ₹12.32 Cr | ₹15.3 Cr | ₹13.07 Cr | ₹18.85 Cr | ₹20.29 Cr |
| Depreciation & Amortisation | ₹13.92 Cr | ₹13.55 Cr | ₹13.52 Cr | ₹13.5 Cr | ₹12.84 Cr | ₹12.34 Cr | ₹12.3 Cr |
| Other Expenses | ₹94.88 Cr | ₹76.11 Cr | ₹64.24 Cr | ₹63.76 Cr | ₹74.63 Cr | ₹73.55 Cr | ₹54.98 Cr |
| Total Expenses | ₹503.12 Cr | ₹440.54 Cr | ₹464.52 Cr | ₹556.28 Cr | ₹493.02 Cr | ₹442.36 Cr | ₹386.17 Cr |
| Profit Before Exceptional Items & Tax | ₹66.88 Cr | ₹21.37 Cr | -₹30.25 Cr | -₹22.3 Cr | ₹95.74 Cr | ₹8.47 Cr | -₹64.11 Cr |
| Exceptional Items | ₹3.39 Cr | -₹7.88 Cr | -₹26.66 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹70.28 Cr | ₹13.49 Cr | -₹56.9 Cr | -₹22.3 Cr | ₹95.74 Cr | ₹8.47 Cr | -₹64.11 Cr |
| Total Tax Expense | ₹17.39 Cr | ₹5.24 Cr | -₹15.31 Cr | -₹6.29 Cr | ₹23.81 Cr | ₹2.71 Cr | ₹10.89 Cr |
| Net Profit | ₹52.88 Cr | ₹8.25 Cr | -₹41.59 Cr | -₹16.02 Cr | ₹71.93 Cr | ₹5.76 Cr | -₹75 Cr |
| attributable to Owners | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| attributable to NCI | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | ₹2.67 Cr | -₹2.44 Cr | -₹72.57 Lakh | ₹1.42 Cr | -₹12.73 Lakh | -₹27.56 Lakh | ₹37.59 Lakh |
| Total Comprehensive Income | ₹55.55 Cr | ₹5.81 Cr | -₹42.32 Cr | -₹14.59 Cr | ₹71.8 Cr | ₹5.49 Cr | -₹74.62 Cr |
| EBITDA (computed) | ₹92.11 Cr | ₹45.13 Cr | -₹4.41 Cr | ₹6.5 Cr | ₹121.66 Cr | ₹39.66 Cr | -₹31.52 Cr |
| Basic EPS | ₹10.33 | ₹1.61 | ₹-8.13 | ₹-3.13 | ₹14.05 | ₹1.31 | ₹-17.88 |
| Diluted EPS | ₹10.33 | ₹1.61 | ₹-8.13 | ₹-3.13 | ₹14.05 | ₹1.31 | ₹-17.88 |
| Segment · Q4 FY26 (latest quarter) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Sugar | ₹540.9 Cr | ₹60.88 Cr | ₹796.12 Cr | ₹828.38 Cr |
| Cogeneration | ₹82.76 Cr | ₹12.12 Cr | ₹85.02 Cr | ₹12.01 Cr |
| Bio Based Chemicals | ₹147.36 Cr | ₹7.36 Cr | ₹476.96 Cr | ₹164.67 Cr |
| Distillery | ₹220.68 Cr | ₹2.97 Cr | ₹679.24 Cr | ₹216 Cr |
| Unallocated | ₹5.39 Cr | -₹1.75 Cr | ₹0 | ₹0 |
| Segment · FY 2026 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Sugar | ₹1,279.45 Cr | ₹23.04 Cr | - | - |
| Cogeneration | ₹160.28 Cr | -₹3.61 Cr | - | - |
| Bio Based Chemicals | ₹577.99 Cr | ₹36.31 Cr | - | - |
| Distillery | ₹663.65 Cr | ₹9.47 Cr | - | - |
| Unallocated | ₹26.8 Cr | -₹11.52 Cr | - | - |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Revenue from Operations | ₹1,964.92 Cr | ₹1,853.17 Cr |
| Other Income | ₹11.46 Cr | ₹16.04 Cr |
| Total Income | ₹1,976.39 Cr | ₹1,869.21 Cr |
| Cost of Materials Consumed | ₹1,488.44 Cr | ₹1,242.31 Cr |
| Purchases of Stock-in-Trade | ₹6.83 Cr | ₹5.44 Cr |
| Changes in Inventories | -₹82.59 Cr | ₹127.85 Cr |
| Employee Benefit Expense | ₹130.6 Cr | ₹121.8 Cr |
| Finance Costs | ₹48.45 Cr | ₹71.61 Cr |
| Depreciation & Amortisation | ₹54.32 Cr | ₹49.86 Cr |
| Other Expenses | ₹297.66 Cr | ₹255.74 Cr |
| Total Expenses | ₹1,943.71 Cr | ₹1,874.61 Cr |
| Profit Before Exceptional Items & Tax | ₹32.67 Cr | -₹5.4 Cr |
| Exceptional Items | -₹31.14 Cr | ₹0 |
| Profit Before Tax | ₹1.53 Cr | -₹5.4 Cr |
| Total Tax Expense | ₹29.6 Lakh | ₹21.76 Cr |
| Net Profit | ₹1.24 Cr | -₹27.16 Cr |
| Other Comprehensive Income | -₹2.69 Cr | ₹35.96 Lakh |
| Total Comprehensive Income | -₹1.45 Cr | -₹26.8 Cr |
| EBITDA (computed) | ₹135.43 Cr | ₹116.06 Cr |
| Basic EPS | ₹0.24 | ₹-5.92 |
| Diluted EPS | ₹0.24 | ₹-5.92 |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Total Assets | ₹2,028.37 Cr | ₹1,943.82 Cr |
| Non-current Assets | ₹1,077.16 Cr | ₹947.99 Cr |
| Current Assets | ₹951.21 Cr | ₹995.82 Cr |
| Property, Plant & Equipment | ₹863.79 Cr | ₹861.27 Cr |
| Inventories | ₹759.97 Cr | ₹732.61 Cr |
| Trade Receivables | ₹103.7 Cr | ₹129.53 Cr |
| Cash & Equivalents | ₹2.15 Cr | ₹1.5 Cr |
| Equity (Net Worth) | ₹773.01 Cr | ₹772.59 Cr |
| Equity Share Capital | ₹51.18 Cr | ₹51.18 Cr |
| Borrowings (Non-current) | ₹330.93 Cr | ₹239.74 Cr |
| Borrowings (Current) | ₹193.38 Cr | ₹248.33 Cr |
| Total Debt (computed) | ₹524.31 Cr | ₹488.08 Cr |
| Current Liabilities | ₹868.09 Cr | ₹882.24 Cr |
| Total Liabilities | ₹1,255.36 Cr | ₹1,171.23 Cr |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Operating Cash Flow | ₹173.4 Cr | -₹1.33 Cr |
| Investing Cash Flow | -₹163.25 Cr | -₹60.94 Cr |
| Financing Cash Flow | -₹9.5 Cr | ₹62.57 Cr |
| Capital Expenditure | ₹168.35 Cr | ₹71.25 Cr |
| Free Cash Flow (computed) | ₹5.05 Cr | -₹72.58 Cr |
| Dividends Paid | ₹0 | ₹0 |
| Net Change in Cash | ₹65.32 Lakh | ₹29.96 Lakh |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹562.11 Cr | ₹456.88 Cr | ₹422.81 Cr | ₹523.12 Cr | ₹575.7 Cr | ₹445.37 Cr | ₹315.94 Cr |
| Other Income | ₹5.76 Cr | ₹1.81 Cr | ₹3.31 Cr | ₹59.36 Lakh | ₹9.41 Cr | ₹3.07 Cr | ₹93.03 Lakh |
| Total Income | ₹567.86 Cr | ₹458.69 Cr | ₹426.12 Cr | ₹523.72 Cr | ₹585.11 Cr | ₹448.43 Cr | ₹316.87 Cr |
| Cost of Materials Consumed | ₹681.63 Cr | ₹455.54 Cr | ₹146 Cr | ₹205.26 Cr | ₹575.57 Cr | ₹446.44 Cr | ₹92.41 Cr |
| Purchases of Stock-in-Trade | ₹1.33 Cr | ₹1.67 Cr | ₹1.98 Cr | ₹1.86 Cr | ₹1.39 Cr | ₹1.71 Cr | ₹1.39 Cr |
| Changes in Inventories | -₹335.72 Cr | -₹152.88 Cr | ₹189.33 Cr | ₹216.68 Cr | -₹220.12 Cr | -₹142.19 Cr | ₹172.33 Cr |
| Employee Benefit Expense | ₹35.2 Cr | ₹33.73 Cr | ₹30.51 Cr | ₹31.17 Cr | ₹33.91 Cr | ₹29.45 Cr | ₹28.79 Cr |
| Finance Costs | ₹11.25 Cr | ₹10.01 Cr | ₹12.22 Cr | ₹14.97 Cr | ₹12.87 Cr | ₹19 Cr | ₹20.18 Cr |
| Depreciation & Amortisation | ₹13.87 Cr | ₹13.52 Cr | ₹13.47 Cr | ₹13.45 Cr | ₹12.79 Cr | ₹12.29 Cr | ₹12.25 Cr |
| Other Expenses | ₹94.13 Cr | ₹75.95 Cr | ₹64.14 Cr | ₹63.45 Cr | ₹74.74 Cr | ₹73.08 Cr | ₹55.11 Cr |
| Total Expenses | ₹501.68 Cr | ₹437.55 Cr | ₹457.64 Cr | ₹546.85 Cr | ₹491.15 Cr | ₹439.77 Cr | ₹382.45 Cr |
| Profit Before Exceptional Items & Tax | ₹66.18 Cr | ₹21.14 Cr | -₹31.52 Cr | -₹23.13 Cr | ₹93.96 Cr | ₹8.66 Cr | -₹65.58 Cr |
| Exceptional Items | ₹3.4 Cr | -₹7.88 Cr | -₹26.66 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹69.57 Cr | ₹13.27 Cr | -₹58.18 Cr | -₹23.13 Cr | ₹93.96 Cr | ₹8.66 Cr | -₹65.58 Cr |
| Total Tax Expense | ₹17.16 Cr | ₹5.17 Cr | -₹15.55 Cr | -₹6.48 Cr | ₹23.88 Cr | ₹2.55 Cr | ₹10.89 Cr |
| Net Profit | ₹52.41 Cr | ₹8.1 Cr | -₹42.63 Cr | -₹16.64 Cr | ₹70.08 Cr | ₹6.11 Cr | -₹76.46 Cr |
| Other Comprehensive Income | -₹45.43 Lakh | -₹65.92 Lakh | -₹1.57 Cr | ₹0 | ₹29.24 Lakh | ₹11.32 Lakh | ₹0 |
| Total Comprehensive Income | ₹51.96 Cr | ₹7.44 Cr | -₹44.2 Cr | -₹16.64 Cr | ₹70.37 Cr | ₹6.22 Cr | -₹76.46 Cr |
| EBITDA (computed) | ₹91.3 Cr | ₹44.68 Cr | -₹5.83 Cr | ₹5.3 Cr | ₹119.62 Cr | ₹39.95 Cr | -₹33.15 Cr |
| Basic EPS | ₹10.24 | ₹1.58 | ₹-8.33 | ₹-3.25 | ₹13.69 | ₹1.38 | ₹-18.23 |
| Diluted EPS | ₹10.24 | ₹1.58 | ₹-8.33 | ₹-3.25 | ₹13.69 | ₹1.38 | ₹-18.23 |
| Segment · Q4 FY26 (latest quarter) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Sugar | ₹542.05 Cr | ₹60.44 Cr | ₹797.74 Cr | ₹819.69 Cr |
| Cogeneration | ₹82.76 Cr | ₹12.12 Cr | ₹85.02 Cr | ₹12.01 Cr |
| Bio Based Chemicals | ₹149.6 Cr | ₹7.04 Cr | ₹466.37 Cr | ₹164.65 Cr |
| Distillery | ₹220.68 Cr | ₹2.97 Cr | ₹679.24 Cr | ₹216 Cr |
| Unallocated | ₹0 | -₹1.74 Cr | ₹0 | ₹0 |
| Segment · FY 2026 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Sugar | ₹1,285.65 Cr | ₹20.78 Cr | - | - |
| Cogeneration | ₹160.28 Cr | -₹3.61 Cr | - | - |
| Bio Based Chemicals | ₹575.57 Cr | ₹34.85 Cr | - | - |
| Distillery | ₹663.65 Cr | ₹9.47 Cr | - | - |
| Unallocated | ₹0 | -₹11.52 Cr | - | - |
Board & Governance of Godavari Biorefineries Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Godavari Biorefineries Limited has 10 directors - 5 independent and 4 executive. The board is chaired by Samir Shantilal Somaiya.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Samir Shantilal Somaiya | Executive Director · MD · Chairperson | 2007-06-22 | 1 |
| Sangeeta Arunkumar Srivastava | Executive Director | 2020-08-01 | 1 |
| Bhalachandra Raghavendra Bakshi | Executive Director | 2018-06-01 | 1 |
| Suhas Uttam Godage | Executive Director | 2021-09-08 | 1 |
| Lakshmi Kantam Mannepalli | Non-Executive - Independent Director | 2017-11-28 | 3 |
| Hemant Luthra | Non-Executive - Independent Director | 2020-10-30 | 1 |
| Kumar Desai | Non-Executive - Independent Director | 2024-09-16 | 1 |
| Nitin Mehta | Non-Executive - Independent Director | 2021-07-01 | 1 |
| Raman Ramachandran | Non-Executive - Non Independent Director | 2023-11-30 | 1 |
| Sean E Reagan | Non-Executive - Independent Director | 2025-09-30 | 1 |
| Nandan Mehta | Non-Executive - Independent Director | 2025-09-30 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | Hemant Luthra (Chairperson), Lakshmi Kantam Mannepalli, Sean E Reagan, Samir Shantilal Somaiya |
| Nomination and remuneration committee | Lakshmi Kantam Mannepalli (Chairperson), Hemant Luthra, Nandan Mehta |
| Stakeholders Relationship Committee | Hemant Luthra (Chairperson), Lakshmi Kantam Mannepalli, Nandan Mehta, Raman Ramachandran, Bhalachandra Raghavendra Bakshi |
| Risk Management Committee | Raman Ramachandran (Chairperson), Hemant Luthra, Samir Shantilal Somaiya, Bhalachandra Raghavendra Bakshi, Sangeeta Arunkumar Srivastava, Suhas Uttam Godage, Sean E Reagan, Lakshmi Kantam Mannepalli, Nitin Mehta |
| Corporate Social Responsibility Committee | Lakshmi Kantam Mannepalli (Chairperson), Hemant Luthra, Bhalachandra Raghavendra Bakshi, Suhas Uttam Godage |
Charges & Borrowings of Godavari Biorefineries Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jul 2025 | Karnataka Bank Ltd. | ₹45 Cr | Open |
| 30 Jun 2025 | Others | ₹50 Cr | Open |
| 22 Apr 2025 | Others | ₹50 Cr | Open |
| 26 Dec 2024 | Idbi Trusteeship Services Limited | ₹119 Cr | Open |
| 30 Aug 2024 | Idbi Trusteeship Services Limited | ₹50 Cr | Open |
Total charge records: 60 View all charges
Employees and EPFO Compliance at Godavari Biorefineries Limited
View historical data on people associated with Godavari Biorefineries Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Godavari Biorefineries Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Godavari Biorefineries Limited
GSTIN & GST Filing Data of Godavari Biorefineries Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Godavari Biorefineries Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Godavari Biorefineries Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Godavari Biorefineries Limited
MSME Payment Delays by Godavari Biorefineries Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Godavari Biorefineries Limited
Subsidiaries & Group Companies of Godavari Biorefineries Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Godavari Biorefineries Limited with ownership details.
MCA Filings & Documents of Godavari Biorefineries Limited
MCA Filings & Documents of Godavari Biorefineries Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Godavari Biorefineries Limited
Recent News on Godavari Biorefineries Limited
Frequently Asked Questions about Godavari Biorefineries Limited
Godavari Biorefineries Limited is an active public limited company in the chemicals and materials sector based in Mumbai, Maharashtra, India. It was incorporated on 12 January 1956 (70+ years old) and is registered under CIN L67120MH1956PLC009707. The company has 1,482 employees.
Godavari Biorefineries Limited reported revenue of ₹1,886.91 Cr for FY 2025 (up 11.00% YoY).
The current directors of Godavari Biorefineries Limited are:
The primary industry of Godavari Biorefineries Limited is chemicals and materials. The company specifically operates in organic chemicals and compounds. The company is currently active in this sector.
Yes, Godavari Biorefineries Limited is a listed company.
Godavari Biorefineries Limited can be reached at the registered office: Somaiya Bhavan 4547 M. G. Road Fort, Mumbai, Maharashtra, India – 400001, or through the website somaiya.com.